Given the conflicting findings regarding visfatin’s prognostic significance, studies should also stratify patients by metabolic status (obesity, diabetes, metabolic syndrome) to determine whether visfatin’s role is context-dependent. This evidence concerns the gene NAMPT and diabetes mellitus.